Free Trial

Johnsons Controls Q3 Revenue Miss Sees Negative Guidance Tweak

HEALTHCARE

Rating: Baa2[P]/BBB+


Revenue slightly soft which looks to have fed through to a negative org revenue guidance tweak though this was accompanied by an improved margin guidance. Cash flow looks strong YoY while leverage broadly flat from Q1. Equity headlines imply a strong pre-market move higher on the narrowed EPS guidance range with the new range looking ahead of consensus.


  • Q3 revenues +1.4% YoY (-1.7% vs. BBG consensus) or +3% organically.
  • Gross profit margin stable YoY at 34.4% vs. 34.1% last year.
  • CFO of USD 1bn from USD 813mn last year. EBITDA leverage of 2.3x from 2.4x at Q2 and 2.1x at Q323.
  • FY guidance tightened with organic sales growth seen ~3% YoY (from MSDs before), EBITA margin improvement of 110bps (from 50-75bps) and EPS before special items of USD 3.66-3.69 (from USD 3.60-3.75).

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.